This willingness increases with age.
Two additional medications are approved to treat certain symptoms of Alzheimers disease such as agitation and psychosis.
Nearly three-quarters of older adults (74 percent) said they would take medication to manage their symptoms.
Buildup of p-tau217 over time is a biomarker that correlates with declining cognition and brain atrophy.
This blood test isin development but not yet widely available for use in doctors offices.
Most adults said they understand that early-stage diagnosis of dementia would enable more effective treatment.
For more information, just contact Laura Mehegan atlmehegan@aarp.org.
For media inquiries, contact External Relations atmedia@aarp.org.
About one-third of those incidents were likely traumatic brain injuries.
Adults 65-plus are at greatest risk.
